FXStreet
Amgen stock gained more than 2% in Friday’s morning session after foreign weightloss drug competitor NovoNordisk (NVO) plunged following the results of new drug testing…
Read More
Amgen stock gains on Novo Nordisk’s weightloss drug blunder
Amgen stock gained more than 2% in Friday’s morning session after foreign weightloss drug competitor NovoNordisk (NVO) plunged following the results of new drug testing…